Post-Traumatic Stress Disorder Therapeutics Global Market Report 2024

Description

“Post-Traumatic Stress Disorder Therapeutics Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on post-traumatic stress disorder therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for post-traumatic stress disorder therapeutics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The post-traumatic stress disorder therapeutics market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Drug Class: Antidepressants; Anti-Anxiety; Antihypertensive; Monoamine Oxidase (MAOs); Antipsychotics Or Second Generation Antipsychotics (SGOs); Beta-Blockers; Other Classes
2) By Age Group: Pediatric; Geriatric; Adult
3) By End User: Mental Health Center; Hospitals; Outpatient Clinics; Other End Users
Companies Mentioned: Novartis AG; Pfizer Inc.; GlaxoSmithKline plc; Bionomics Limited; Apotex Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Post-traumatic stress disorder (PTSD) therapeutics pertain to treatments employed for addressing the mental health condition triggered by either experiencing or witnessing traumatic events. The goal of post-traumatic stress disorder treatment is to enhance cognitive functioning, instigate changes in physical activity, and assist individuals in regaining a sense of control over their lives. Treatment modalities for PTSD encompass medication, various therapies, self-care practices, and nutritional interventions.

Key drugs utilized in post-traumatic stress disorder therapeutics encompass antidepressants, anti-anxiety medications, antihypertensive drugs, monoamine oxidase inhibitors (MAOIs), antipsychotics or second-generation antipsychotics (SGAs), beta-blockers, and others (including benzodiazepines and others). Antidepressants, a specific class of drugs, are employed to manage addictions and address conditions such as major depressive disorder, anxiety disorders, and chronic pain. The therapeutic interventions are administered across diverse age groups, including pediatric, geriatric, and adult populations, and are utilized by various end-users, including mental health centers, hospitals, outpatient clinics, and other healthcare facilities.

The post-traumatic stress disorder therapeutics market research report is one of a series of new reports from The Business Research Company that provides post-traumatic stress disorder therapeutics market statistics, including post-traumatic stress disorder therapeutics industry global market size, regional shares, competitors with a post-traumatic stress disorder therapeutics market share, detailed sulfuric acid market segments, market trends and opportunities, and any further data you may need to thrive in the post-traumatic stress disorder therapeutics industry. This sulfuric acid market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The post-traumatic stress disorder therapeutics market size has grown strongly in recent years. It will grow from $1.09 billion in 2023 to $1.15 billion in 2024 at a compound annual growth rate (CAGR) of 5.1%. The growth observed in the historical period can be attributed to factors such as heightened awareness, increased incidence of trauma, government initiatives, advancements in diagnostic tools, efforts to reduce stigma, and the implementation of psychological support programs with a specific focus on veteran healthcare.

The post-traumatic stress disorder therapeutics market size is expected to see steady growth in the next few years. It will grow to $1.35 billion in 2028 at a compound annual growth rate (CAGR) of 4.1%. The anticipated growth in the forecast period can be attributed to the expansion of access to mental health services, the implementation of government mental health policies, advancements in biological and neurological research, the consideration of PTSD in non-military populations, and the development of crisis response planning. Key trends expected in the forecast period encompass the integration of digital therapeutics, progress in pharmacological treatments, the exploration of neurostimulation and brain stimulation techniques, the emergence of psychedelic-assisted therapy, and collaborative research initiatives.

The anticipated increase in the prevalence of post-traumatic stress disorder (PTSD) cases worldwide is expected to drive the growth of the market for therapeutics addressing PTSD. PTSD is a condition that develops in individuals who have experienced a frightening, shocking, or dangerous event. Treatment options for post-traumatic stress disorder, such as psychotherapy and medication, play a crucial role in helping individuals regain control over their lives. For instance, the United States Department of Veterans Affairs reported that nearly 8 million Americans were grappling with PTSD in 2021, highlighting the surge in PTSD cases as a key driver for the growth of the post-traumatic stress disorder therapeutics market.

The increasing incidence of mental health issues is projected to contribute to the expansion of the post-traumatic stress disorder (PTSD) therapeutic market. Mental health issues encompass a broad spectrum of conditions affecting an individual's thinking, perceptions, feelings, and behaviors. Therapeutics for PTSD address mental health issues through a combination of psychotherapy, medication, and other interventions. According to a 2022 survey by the House of Commons Library, 18.0% of children aged 7-16 were identified with a probable mental disorder in 2022, with an expected rise to 25.7% in 2022. Consequently, the growing prevalence of mental health issues is a key factor driving the growth of the post-traumatic stress disorder (PTSD) therapeutic market.

Strategic collaborations, funding, and investments have emerged as a prominent trend in the post-traumatic stress disorder therapeutics market. Major companies in the market are forming strategic collaborations and investing in various initiatives to fortify their positions. In January 2022, Professor Dan Lubman AM, Dr. Shalini Arunogiri, and Dr. Paul Liknaitzky of Monash University secured over $1.9 million for a study on the effectiveness of MDMA-assisted psychological treatment for alcohol use disorder (AUD) and PTSD. This initiative, part of the Medical Research Future Fund (MRFF), is one of seven clinical studies aiming to evaluate the potential of combination medicines for treating severe mental disorders.

Leading organizations in the post-traumatic stress disorder therapeutics market are actively establishing innovative research centers, including psychedelics research centers, to explore psychedelic compounds and gain a competitive edge. Psychedelics research centers focus on studying the therapeutic applications of psychedelic compounds and developing new treatments for mental health disorders. For example, in January 2021, the Mount Sinai Health System launched the Center for Psychedelic Psychotherapy and Trauma Research, dedicated to researching psilocybin, MDMA, and other psychedelic substances. The center aims to conduct clinical trials necessary for the widespread use of psychedelic-assisted psychotherapies.

In June 2023, Stella Center, a U.S.-based provider of PTSD treatment, acquired the U.S. assets of Field Trip Health for an undisclosed amount. This acquisition is expected to expand Stella's range of advanced treatments, including Field Trip Health's outcomes data, research, technology stack, clinics, and leadership. Field Trip Health, a Canada-based provider of psychedelic-assisted therapies for mental health conditions, including PTSD, is the focus of this strategic move.

Major companies operating in the post-traumatic stress disorder therapeutics market report are Novartis AG, Pfizer Inc., GlaxoSmithKline plc, Bionomics Limited, Apotex Inc., Otsuka Pharmaceutical Co Ltd., Eli Lilly and Company, Behavioral Health Network Inc., AstraZeneca plc, Prometheon Pharma LLC, Tonix Pharmaceuticals Holding Corp., Freespira Inc., MicroTransponder Inc., Addex Therapeutics Ltd., Stella Center, Neurovation Labs Inc., Equip Global Pte Ltd., Compass Pathways plc, Boehringer Ingelheim International GmbH, Halucenex Life Sciences Inc., Bionorica SE, MAPS Europe BV, Hoffmann-La Roche Ltd., Praxis Precision Medicines Inc., H Lundbeck A/S, Johnson & Johnson, Sanofi SA, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Amgen Inc., Biogen Inc., Gilead Sciences Inc., Regeneron Pharmaceuticals Inc., Aurobindo Pharma Limited, Merck KGaA, Sun Pharmaceuticals Industries Limited, Strategic Behavioral Health, Jazz Pharmaceuticals plc .

North America was the largest region in the post-traumatic stress disorder therapeutics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the post-traumatic stress disorder therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the post-traumatic stress disorder therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The post-traumatic stress disorder therapeutics market consists of revenues earned by entities by providing treatment services such as psychotherapy, medication, and the combination. The market value includes the value of related goods sold by the service provider or included within the service offering. The post-traumatic stress disorder therapeutics market also includes sales of drugs including Sertraline, Paroxetine, and Fluoxetine. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r11254

1. Executive Summary

2. Post-Traumatic Stress Disorder Therapeutics Market Characteristics

3. Post-Traumatic Stress Disorder Therapeutics Market Trends And Strategies

4. Post-Traumatic Stress Disorder Therapeutics Market - Macro Economic Scenario

4.1. Impact Of High Inflation On the Market
4.2. Ukraine-Russia War Impact On the Market
4.3. COVID-19 Impact On the Market

5. Global Post-Traumatic Stress Disorder Therapeutics Market Size and Growth

5.1. Global Post-Traumatic Stress Disorder Therapeutics Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Post-Traumatic Stress Disorder Therapeutics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Post-Traumatic Stress Disorder Therapeutics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Post-Traumatic Stress Disorder Therapeutics Market Segmentation

6.1. Global Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Antidepressants
Anti-Anxiety
Antihypertensive
Monoamine Oxidase (MAOs)
Antipsychotics Or Second Generation Antipsychotics (SGOs)
Beta-Blockers
Other Classes
6.2. Global Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Pediartic
Geriatric
Adult
6.3. Global Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Mental Health Center
Hospitals
Outpaitent Clinics
Other End Users

7. Post-Traumatic Stress Disorder Therapeutics Market Regional And Country Analysis

7.1. Global Post-Traumatic Stress Disorder Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Post-Traumatic Stress Disorder Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market

8.1. Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Post-Traumatic Stress Disorder Therapeutics Market

9.1. China Post-Traumatic Stress Disorder Therapeutics Market Overview
9.2. China Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Post-Traumatic Stress Disorder Therapeutics Market

10.1. India Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Post-Traumatic Stress Disorder Therapeutics Market

11.1. Japan Post-Traumatic Stress Disorder Therapeutics Market Overview
11.2. Japan Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Post-Traumatic Stress Disorder Therapeutics Market

12.1. Australia Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Post-Traumatic Stress Disorder Therapeutics Market

13.1. Indonesia Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Post-Traumatic Stress Disorder Therapeutics Market

14.1. South Korea Post-Traumatic Stress Disorder Therapeutics Market Overview
14.2. South Korea Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Post-Traumatic Stress Disorder Therapeutics Market

15.1. Western Europe Post-Traumatic Stress Disorder Therapeutics Market Overview
15.2. Western Europe Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Post-Traumatic Stress Disorder Therapeutics Market

16.1. UK Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Post-Traumatic Stress Disorder Therapeutics Market

17.1. Germany Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Post-Traumatic Stress Disorder Therapeutics Market

18.1. France Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Post-Traumatic Stress Disorder Therapeutics Market

19.1. Italy Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Post-Traumatic Stress Disorder Therapeutics Market

20.1. Spain Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Post-Traumatic Stress Disorder Therapeutics Market

21.1. Eastern Europe Post-Traumatic Stress Disorder Therapeutics Market Overview
21.2. Eastern Europe Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Post-Traumatic Stress Disorder Therapeutics Market

22.1. Russia Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Post-Traumatic Stress Disorder Therapeutics Market

23.1. North America Post-Traumatic Stress Disorder Therapeutics Market Overview
23.2. North America Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Post-Traumatic Stress Disorder Therapeutics Market

24.1. USA Post-Traumatic Stress Disorder Therapeutics Market Overview
24.2. USA Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Post-Traumatic Stress Disorder Therapeutics Market

25.1. Canada Post-Traumatic Stress Disorder Therapeutics Market Overview
25.2. Canada Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Post-Traumatic Stress Disorder Therapeutics Market

26.1. South America Post-Traumatic Stress Disorder Therapeutics Market Overview
26.2. South America Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Post-Traumatic Stress Disorder Therapeutics Market

27.1. Brazil Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Post-Traumatic Stress Disorder Therapeutics Market

28.1. Middle East Post-Traumatic Stress Disorder Therapeutics Market Overview
28.2. Middle East Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Post-Traumatic Stress Disorder Therapeutics Market

29.1. Africa Post-Traumatic Stress Disorder Therapeutics Market Overview
29.2. Africa Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Post-Traumatic Stress Disorder Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Post-Traumatic Stress Disorder Therapeutics Market Competitive Landscape And Company Profiles

30.1. Post-Traumatic Stress Disorder Therapeutics Market Competitive Landscape
30.2. Post-Traumatic Stress Disorder Therapeutics Market Company Profiles
- 30.2.1. Novartis AG
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Pfizer Inc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. GlaxoSmithKline plc
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Bionomics Limited
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Apotex Inc.
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Global Post-Traumatic Stress Disorder Therapeutics Market Competitive Benchmarking

32. Global Post-Traumatic Stress Disorder Therapeutics Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Post-Traumatic Stress Disorder Therapeutics Market

34. Post-Traumatic Stress Disorder Therapeutics Market Future Outlook and Potential Analysis

34.1 Post-Traumatic Stress Disorder Therapeutics Market In 2028 - Countries Offering Most New Opportunities
34.2 Post-Traumatic Stress Disorder Therapeutics Market In 2028 - Segments Offering Most New Opportunities
34.3 Post-Traumatic Stress Disorder Therapeutics Market In 2028 - Growth Strategies
- 34.3.1 Market Trend Based Strategies
- 34.3.2 Competitor Strategies

35. Appendix

35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer